(Health-NewsWire.Net, July 31, 2018 ) This PharmSource Trend Report will explore whether the bio/pharma industry is adequately prepared for future cell therapy developments and whether pharma companies and contract manufacturing organizations (CDMOs) are making appropriate investments in the capacity and technology to support the coming opportunity.
This 35-page report gives important, expert insight you won’t find in any other source. 16 tables and figures throughout the report illustrate major points and trends.
Scope: This report seeks to achieve the following objectives - - To describe and evaluate the cell therapy market opportunity; - To describe and address the adequacy of the network of CDMOs that manufacture for the cell therapy market, both clinical and commercial; - To assess the outlook for buyers and sellers of contract manufacturing services for cell therapies, including the supply/demand balance.
Reasons to buy: This report is required reading for - - CMO executives who must have deep understanding of the Cell Therapy marketplace to make strategic planning and investment decisions. - Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. - Pharmaceutical and Biotech companies involved in the development of Cell Therapies or Cell Therapy technologies. - Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Key Players: Cellectis China PLA General Hospital GSK 3P Biopharmaceuticals Abzena Anemocyte SRL apceth Biopharma GmbH Areta International Army Military Medical University (formerly Third Military Medical University) Astellas Atvio Biotech Ltd Austrianova Singapore Pte. Ltd. Autolus Bio Elpida Bioinova sro Brammer Bio CCRM Celgene Cell and Gene Therapy Catapult CellforCure Cellin Technologies LLC Cellular Therapeutics Ltd. Celularity City of Hope Cognate Bioservices Cook General BioTechnology, LLC Dendreon Pharmaceuticals LLC Esperite Fraunhofer Group GE Healthcare Gencure Gilead Sciences Inc. Histocell SL Hitachi Chemical Co Ltd Hitachi Chemical Co., Ltd. Holostem Terapie Avanzate Incell Corporation LLC International Stem Cell Corporation Japan Tissue Engineering Johnson & Johnson KBI Biopharma Kite Kite Pharma Inc. Lonza Group Lonza Netherlands MaSThercell Medinet MolMed SpA New York Blood Center, Inc Newcastle University NHS Blood and Transplant Nikon Corporation Novartis International AG Novartis Pharmaceuticals Corp. Organogenesis Inc. Oxford Biomedica Pfizer Provia Laboratories LLC Roslin Cell Therapies Sanpower Group Co Ltd Sanquin Blood Supply Foundation Shenzhen Geno-Immune Medical Institute Stem Cell and Cancer Institute (SCI) Takara Bio University College London University of Edinburgh University of Miami Health System University of Minnesota University of Pittsburgh University of Utah Health Vericel Corp. WuXi AppTec Yposkesi
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.